Zeng P, Wang Y, Zheng Y, Song X, Yin Y. Cancer?testis antigen HCA587/MAGEC2 interacts with the general transcription coactivator TAF9 in cancer cells. Mol Med Rep. 2018;17:3226-3231 pubmed publisher

Curioni Fontecedro A, Pitocco R, Schoenewolf N, Holzmann D, Soldini D, Dummer R, et al. Intratumoral Heterogeneity of MAGE-C1/CT7 and MAGE-C2/CT10 Expression in Mucosal Melanoma. Biomed Res Int. 2015;2015:432479 pubmed publisher

Bode P, Barghorn A, Fritzsche F, Riener M, Kristiansen G, Knuth A, et al. MAGEC2 is a sensitive and novel marker for seminoma: a tissue microarray analysis of 325 testicular germ cell tumors. Mod Pathol. 2011;24:829-35 pubmed

Zhuang R, Zhu Y, Fang L, Liu X, Tian Y, Chen L, et al. Generation of monoclonal antibodies to cancer/testis (CT) antigen CT10/MAGE-C2. Cancer Immun. 2006;6:7 pubmed